Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 140 blog entries.

Extended FP34C submission deadline for prescriptions dispensed in March 2024

With Easter Monday (1 April 2024) occurring in the first five days of the FP34C submission window, pharmacy owners will have an extra day, until the end of 6 April 2024, to submit their March FP34Cs using the Manage Your Service (MYS) portal and to dispatch their prescription bundle to the relevant pricing division at the [...]

The post Extended FP34C submission deadline for prescriptions dispensed in March 2024 appeared first on Community Pharmacy England.

By |March 27th, 2024|Lexpos News|Comments Off on Extended FP34C submission deadline for prescriptions dispensed in March 2024

New SSP issued for Monomil® XL 60mg tablets

In response to a significant ongoing disruption to the supply of Monomil® XL 60mg tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 26th March 2024,  SSP059 provides that for every Monomil® XL 60mg tablets originally prescribed one alternative brand of a Isosorbide mononitrate 60mg modified-release tablets [...]

The post New SSP issued for Monomil® XL 60mg tablets appeared first on Community Pharmacy England.

By |March 26th, 2024|Lexpos News|Comments Off on New SSP issued for Monomil® XL 60mg tablets

MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd)

Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) Drug alert number: EL (24)A/07 Date issued: 26 February 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm [...]

The post MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) appeared first on Community Pharmacy England.

By |February 26th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd)

National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials

National Patient Safety Alert: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials National Patient Safety Alert Reference Number: NatPSA/2024/003/DHSC_MVA Date issued: 26 February 2024 Explanation of identified safety issue A Medicines Supply Notification (MSN) issued on 14 February 2024, detailed a shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid. The resolution date [...]

The post National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials appeared first on Community Pharmacy England.

By |February 26th, 2024|Lexpos News|Comments Off on National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials

February 2024 Price Concessions 3rd Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (23/02/2024) announced the following list of price concessions for February 2024. Please note: We are still in discussion with DHSC on a number other medicines affected by pricing [...]

The post February 2024 Price Concessions 3rd Update appeared first on Community Pharmacy England.

By |February 23rd, 2024|Lexpos News|Comments Off on February 2024 Price Concessions 3rd Update